id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-P-0573-0004,FDA,FDA-2013-P-0573,FDA/CDER Repsonse to Lupin Pharmaceuticals Inc - Letter,Other,Letter(s),2013-11-26T05:00:00Z,2013,11,2013-11-26T05:00:00Z,,2013-11-26T15:43:18Z,,0,0,0900006481495462
FDA-2013-P-0573-0003,FDA,FDA-2013-P-0573,"Determination That BANZEL (Rufinamide) Tablet, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,General Notice,2013-11-21T05:00:00Z,2013,11,2013-11-21T05:00:00Z,,2013-11-21T14:54:32Z,2013-27874,0,0,090000648148e297
FDA-2013-P-0573-0001,FDA,FDA-2013-P-0573,"Lupin Pharmaceuticals, Inc. - Citizen Petition",Other,Citizen Petition,2013-05-23T04:00:00Z,2013,5,2013-05-23T04:00:00Z,,2024-11-11T20:46:09Z,,1,0,09000064812e5f79
FDA-2013-P-0573-0002,FDA,FDA-2013-P-0573,"Acknowledgement Letter to Lupin Pharmaceuticals, Inc.",Other,Acknowledgement Letter/Receipt,2013-05-23T04:00:00Z,2013,5,2013-05-23T04:00:00Z,,2013-05-23T16:39:11Z,,0,0,09000064812e5f7b